Frequency of C9orf72, GRN, and MAPT pathogenic variants in patients recruited at the Belgrade Memory Center.
Elka StefanovaAna MarjanovićValerija DobričićGorana Mandić-StojmenovićTanja StojkovićMarija BrankovićMaksim ŠarčevićIvana NovakovićVladimir S KostićPublished in: Neurogenetics (2024)
Most of the heritability in frontotemporal dementia (FTD) is accounted for by autosomal dominant hexanucleotide expansion in the chromosome 9 open reading frame 72 (C9orf72), pathogenic/likely pathogenic variants in progranulin (GRN), and microtubule-associated protein tau (MAPT) genes. Until now, there has been no systematic analysis of these genes in the Serbian population. Herein, we assessed the frequency of the C9orf72 expansion, pathogenic/likely pathogenic variants in GRN and MAPT in a well-characterized group of 472 subjects (FTD, Alzheimer's disease - AD, mild cognitive impairment - MCI, and unspecified dementia - UnD), recruited in the Memory Center, Neurology Clinic, University Clinical Center of Serbia. The C9orf72 repeat expansion was detected in 6.98% of FTD cases (13.46% familial; 2.6% sporadic). In the UnD subgroup, C9orf72 repeat expansions were detected in 4.08% (8% familial) individuals. Pathogenic variants in the GRN were found in 2.85% of familial FTD cases. Interestingly, no MAPT pathogenic/likely pathogenic variants were detected, suggesting possible geographical specificity. Our findings highlight the importance of wider implementation of genetic testing in neurological and psychiatric practice managing patients with cognitive-behavioral and motor symptoms.
Keyphrases
- mild cognitive impairment
- copy number
- cognitive decline
- primary care
- working memory
- genome wide
- early onset
- mental health
- ejection fraction
- gene expression
- minimally invasive
- brain injury
- quality improvement
- chronic kidney disease
- depressive symptoms
- prognostic factors
- genome wide identification
- genome wide analysis
- health insurance
- phase iii